Free Trial

HC Wainwright's Rating of Nicox on 8/21/2025

On August 21, 2025, HC Wainwright updated its outlook on Nicox (OTCMKTS:NICXF) with the action "Reiterated Rating", keeping a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from HC Wainwright

DateCompanyAction
9/12/2025
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
Reiterated Rating
9/12/2025
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
Boost Price Target
9/12/2025
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
Reiterated Rating
9/12/2025
Tempus AI, Inc. stock logo
TEM
Tempus AI
Boost Price Target
9/12/2025
Immix Biopharma, Inc. stock logo
IMMX
Immix Biopharma
Boost Price Target
9/12/2025
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
Reiterated Rating
More Ratings From HC Wainwright